Illumina, Inc. (ILMN)
USD 71.27
(-3.07%)
USD 71.27
(-3.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.36 Billion USD | -22.77% |
| 2022 | 5.65 Billion USD | 26.27% |
| 2021 | 4.47 Billion USD | 54.86% |
| 2020 | 2.89 Billion USD | 6.96% |
| 2019 | 2.7 Billion USD | -13.2% |
| 2018 | 3.11 Billion USD | 29.05% |
| 2017 | 2.41 Billion USD | 20.03% |
| 2016 | 2.01 Billion USD | 9.31% |
| 2015 | 1.83 Billion USD | -1.89% |
| 2014 | 1.87 Billion USD | 26.17% |
| 2013 | 1.48 Billion USD | 19.1% |
| 2012 | 1.24 Billion USD | 11.32% |
| 2011 | 1.12 Billion USD | 74.71% |
| 2010 | 641.43 Million USD | 13.39% |
| 2009 | 565.68 Million USD | 7.04% |
| 2008 | 528.5 Million USD | -8.25% |
| 2007 | 576.05 Million USD | 981.95% |
| 2006 | 53.24 Million USD | 89.39% |
| 2005 | 28.11 Million USD | 24.15% |
| 2004 | 22.64 Million USD | -56.32% |
| 2003 | 51.84 Million USD | 3.36% |
| 2002 | 50.16 Million USD | 220.03% |
| 2001 | 15.67 Million USD | 80.31% |
| 2000 | 8.69 Million USD | 366.76% |
| 1999 | 1.86 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.64 Billion USD | 7.87% |
| 2024 Q1 | 4.3 Billion USD | -1.37% |
| 2024 Q3 | 3.57 Billion USD | -16.28% |
| 2023 Q1 | 5.11 Billion USD | -9.46% |
| 2023 FY | 4.36 Billion USD | -22.77% |
| 2023 Q2 | 5.21 Billion USD | 1.97% |
| 2023 Q3 | 4.22 Billion USD | -19.06% |
| 2023 Q4 | 4.36 Billion USD | 3.36% |
| 2022 Q1 | 4.37 Billion USD | -2.19% |
| 2022 Q4 | 5.65 Billion USD | 24.93% |
| 2022 Q3 | 4.52 Billion USD | -9.57% |
| 2022 FY | 5.65 Billion USD | 26.27% |
| 2022 Q2 | 5 Billion USD | 14.27% |
| 2021 Q2 | 3.49 Billion USD | -8.82% |
| 2021 Q4 | 4.47 Billion USD | 0.16% |
| 2021 Q1 | 3.83 Billion USD | 32.58% |
| 2021 FY | 4.47 Billion USD | 54.86% |
| 2021 Q3 | 4.47 Billion USD | 27.9% |
| 2020 Q3 | 2.7 Billion USD | 0.71% |
| 2020 Q1 | 2.62 Billion USD | -2.85% |
| 2020 Q2 | 2.68 Billion USD | 2.25% |
| 2020 Q4 | 2.89 Billion USD | 6.92% |
| 2020 FY | 2.89 Billion USD | 6.96% |
| 2019 FY | 2.7 Billion USD | -13.2% |
| 2019 Q4 | 2.7 Billion USD | 2.0% |
| 2019 Q1 | 3.32 Billion USD | 6.62% |
| 2019 Q2 | 2.64 Billion USD | -20.45% |
| 2019 Q3 | 2.65 Billion USD | 0.34% |
| 2018 Q3 | 3.16 Billion USD | 26.6% |
| 2018 Q1 | 2.46 Billion USD | 2.32% |
| 2018 Q2 | 2.5 Billion USD | 1.26% |
| 2018 FY | 3.11 Billion USD | 29.05% |
| 2018 Q4 | 3.11 Billion USD | -1.61% |
| 2017 FY | 2.41 Billion USD | 20.03% |
| 2017 Q4 | 2.41 Billion USD | 10.13% |
| 2017 Q3 | 2.19 Billion USD | 2.24% |
| 2017 Q2 | 2.14 Billion USD | 5.0% |
| 2017 Q1 | 2.04 Billion USD | 1.52% |
| 2016 FY | 2.01 Billion USD | 9.31% |
| 2016 Q1 | 1.72 Billion USD | -6.33% |
| 2016 Q3 | 1.9 Billion USD | 3.41% |
| 2016 Q2 | 1.84 Billion USD | 7.1% |
| 2016 Q4 | 2.01 Billion USD | 5.36% |
| 2015 Q2 | 1.9 Billion USD | 1.78% |
| 2015 FY | 1.83 Billion USD | -1.89% |
| 2015 Q3 | 1.79 Billion USD | -5.88% |
| 2015 Q4 | 1.83 Billion USD | 2.35% |
| 2015 Q1 | 1.87 Billion USD | 0.06% |
| 2014 Q4 | 1.87 Billion USD | -6.45% |
| 2014 Q2 | 1.95 Billion USD | 32.07% |
| 2014 Q3 | 2 Billion USD | 2.52% |
| 2014 FY | 1.87 Billion USD | 26.17% |
| 2014 Q1 | 1.47 Billion USD | -0.39% |
| 2013 FY | 1.48 Billion USD | 19.1% |
| 2013 Q3 | 1.44 Billion USD | 0.6% |
| 2013 Q2 | 1.43 Billion USD | 0.16% |
| 2013 Q4 | 1.48 Billion USD | 2.95% |
| 2013 Q1 | 1.43 Billion USD | 14.82% |
| 2012 Q4 | 1.24 Billion USD | 2.61% |
| 2012 FY | 1.24 Billion USD | 11.32% |
| 2012 Q3 | 1.21 Billion USD | 4.09% |
| 2012 Q1 | 1.14 Billion USD | 1.85% |
| 2012 Q2 | 1.16 Billion USD | 2.34% |
| 2011 Q3 | 1.11 Billion USD | 2.1% |
| 2011 Q4 | 1.12 Billion USD | 0.82% |
| 2011 FY | 1.12 Billion USD | 74.71% |
| 2011 Q2 | 1.08 Billion USD | 2.81% |
| 2011 Q1 | 1.05 Billion USD | 65.09% |
| 2010 Q1 | 563.41 Million USD | -0.4% |
| 2010 Q4 | 641.43 Million USD | 3.94% |
| 2010 FY | 641.43 Million USD | 13.39% |
| 2010 Q3 | 617.1 Million USD | 2.01% |
| 2010 Q2 | 604.92 Million USD | 7.37% |
| 2009 Q1 | 517.43 Million USD | -2.09% |
| 2009 Q2 | 537.42 Million USD | 3.86% |
| 2009 Q3 | 539.59 Million USD | 0.4% |
| 2009 Q4 | 565.68 Million USD | 4.84% |
| 2009 FY | 565.68 Million USD | 7.04% |
| 2008 Q2 | 500.93 Million USD | 3.36% |
| 2008 Q1 | 484.66 Million USD | -15.87% |
| 2008 FY | 528.5 Million USD | -8.25% |
| 2008 Q4 | 528.5 Million USD | 3.97% |
| 2008 Q3 | 508.32 Million USD | 1.48% |
| 2007 Q4 | 576.05 Million USD | 17.81% |
| 2007 Q3 | 488.95 Million USD | 0.45% |
| 2007 Q2 | 486.73 Million USD | 2.07% |
| 2007 Q1 | 476.87 Million USD | 795.68% |
| 2007 FY | 576.05 Million USD | 981.95% |
| 2006 FY | 53.24 Million USD | 89.39% |
| 2006 Q4 | 53.24 Million USD | 17.27% |
| 2006 Q3 | 45.4 Million USD | 2.53% |
| 2006 Q2 | 44.28 Million USD | 31.0% |
| 2006 Q1 | 33.8 Million USD | 20.24% |
| 2005 FY | 28.11 Million USD | 24.15% |
| 2005 Q3 | 25.92 Million USD | 23.61% |
| 2005 Q1 | 21.35 Million USD | -5.68% |
| 2005 Q2 | 20.97 Million USD | -1.82% |
| 2005 Q4 | 28.11 Million USD | 8.45% |
| 2004 Q1 | 53.5 Million USD | 3.2% |
| 2004 FY | 22.64 Million USD | -56.32% |
| 2004 Q4 | 22.64 Million USD | -2.99% |
| 2004 Q3 | 23.34 Million USD | -58.02% |
| 2004 Q2 | 55.6 Million USD | 3.92% |
| 2003 Q4 | 51.84 Million USD | -6.11% |
| 2003 FY | 51.84 Million USD | 3.36% |
| 2003 Q1 | 51.33 Million USD | 2.33% |
| 2003 Q2 | 50.63 Million USD | -1.36% |
| 2003 Q3 | 55.21 Million USD | 9.05% |
| 2002 FY | 50.16 Million USD | 220.03% |
| 2002 Q1 | 41.42 Million USD | 164.27% |
| 2002 Q2 | 48.92 Million USD | 18.12% |
| 2002 Q4 | 50.16 Million USD | 0.79% |
| 2002 Q3 | 49.77 Million USD | 1.73% |
| 2001 Q1 | 9.44 Million USD | 8.67% |
| 2001 Q3 | 13.93 Million USD | 6.82% |
| 2001 FY | 15.67 Million USD | 80.31% |
| 2001 Q4 | 15.67 Million USD | 12.46% |
| 2001 Q2 | 13.04 Million USD | 38.12% |
| 2000 Q1 | 3.59 Million USD | 0.0% |
| 2000 Q4 | 8.69 Million USD | 6.61% |
| 2000 FY | 8.69 Million USD | 366.76% |
| 2000 Q3 | 8.15 Million USD | 31.8% |
| 2000 Q2 | 6.18 Million USD | 72.05% |
| 1999 FY | 1.86 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -10753.677% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -49631.381% |
| Aspira Women's Health Inc. | 8.62 Million USD | -50508.555% |
| Biodesix, Inc. | 94.51 Million USD | -4519.324% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -250539.947% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -129597.409% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -129597.409% |
| Bionano Genomics, Inc. | 118.24 Million USD | -3592.271% |
| CareDx, Inc | 223.28 Million USD | -1855.331% |
| Check-Cap Ltd. | 1.33 Million USD | -328170.677% |
| Castle Biosciences, Inc. | 86.54 Million USD | -4944.949% |
| DarioHealth Corp. | 38.24 Million USD | -11315.871% |
| Exact Sciences Corporation | 3.32 Billion USD | -31.268% |
| Fulgent Genetics, Inc. | 139.82 Million USD | -3022.519% |
| Guardant Health, Inc. | 1.62 Billion USD | -168.225% |
| ICON Public Limited Company | 7.74 Billion USD | 43.658% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -145.917% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -77924.588% |
| iSpecimen Inc. | 6.07 Million USD | -71732.131% |
| Standard BioTools Inc. | 159.86 Million USD | -2631.054% |
| MDxHealth SA | 121.92 Million USD | -3480.919% |
| 23andMe Holding Co. | 206.64 Million USD | -2012.782% |
| Medpace Holdings, Inc. | 1.09 Billion USD | -297.676% |
| Myriad Genetics, Inc. | 312.9 Million USD | -1295.334% |
| Mainz Biomed B.V. | 12.15 Million USD | -35805.19% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -398564.301% |
| NeoGenomics, Inc. | 739.69 Million USD | -490.246% |
| Neogen Corporation | 1.44 Billion USD | -203.191% |
| Inotiv, Inc. | 588.04 Million USD | -642.466% |
| Natera, Inc. | 691.79 Million USD | -531.109% |
| OpGen, Inc. | 13.44 Million USD | -32375.797% |
| OPKO Health, Inc. | 622.47 Million USD | -601.389% |
| Psychemedics Corporation | 6.59 Million USD | -66071.567% |
| Prenetics Global Limited | 44.01 Million USD | -9819.741% |
| Prenetics Global Limited | 44.01 Million USD | -9819.741% |
| Precipio, Inc. | 3.67 Million USD | -118799.782% |
| Personalis, Inc. | 95.65 Million USD | -4464.177% |
| RadNet, Inc. | 2.07 Billion USD | -110.579% |
| Sera Prognostics, Inc. | 25.28 Million USD | -17168.52% |
| Sotera Health Company | 2.68 Billion USD | -62.505% |
| Neuronetics, Inc. | 81.64 Million USD | -5247.803% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -20043.022% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -20043.022% |
| Trinity Biotech plc | 83.38 Million USD | -5136.017% |
| T2 Biosystems, Inc. | 62.83 Million USD | -6848.578% |
| Twist Bioscience Corporation | 152.97 Million USD | -2754.136% |
| Exagen Inc. | 34.25 Million USD | -12647.445% |